The use of Botulinum toxin in Frey's Syndrome

Irish Medical Journal

Volumn 99, Issue 5, 2006, Pages

  Khoo, S Guan ^a   Timon, Conrad ^a   Keogh, Ivan James ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; FEMALE; FOLLOW UP; FREY SYNDROME; HOSPITAL DISCHARGE; HUMAN; PAROTIDECTOMY; PLEOMORPHIC ADENOMA; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; SYMPTOM;

EID: 33747740096     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Laskawi R, Drobik C, Schonebeck C. Up-to-date report ofbotulinum toxin type A treatment in patients with gustatory sweating (Frey's Syndrome). Laryngoscope 1998; 108: 381-4.
2. Von Lindern JJ, Niederhagen B, Berge S, Hagler G, Reich RH. Frey Syndrome: treatment with type A botulinim toxin. Cancer 2000; 89 (8): 1659-63.
3. Tugnoli V, Marchese Ragona R, Eleopra R, Quatrale R, Capone JG, Pastore A, Montecucco C, De Grandis D. The role of gustatory flushing in Frey's syndrome and its treatment with botulinum. Adv Tech Stand Neurosurg 1984; 11: 169-207
4. Guntinas-Lichius O. Increased botulinum toxin type A dosage is more effective in patients with Frey's syndrome. Laryngoscope 2002; 112 (4): 746-9
5. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope 2001; 111 (2): 218-26.
6. Baillager M. Memoire sur l'mobliteration du canal de Stenon. Gazette Medicale Paris 1853; 23: 194-7
7. Frey L. Le syndrome du nerf auriculotemporal. Rev Neurol (Paris) 1923; 40: 97-104
8. Dulguerov P, Quindodoz D, Cosendai G, Piletta P, Lehmann W. Frey syndrome treatment with botulinum toxin. Otolaryngol Head Neck Surg 2000; 122 (6): 821-26.
9. Beerens AJ, Snow GB. Botulinum toxin A in the treatment of patients with Frey syndrome. Br J Surg 2002; 89 (1): 116-9.
10. Laccourreye O, Akl E, Gutierrez-Fonseca R, Garcia D, Brasnu D, Bonan B. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome. Arch Otolaryngol Head Neck Surg 1999; 125 (3): 283-6.
11. Botox. Allergan patient-physician information leaflet. 2000
12. Klein AW. Complications and adverse reactions with the use of botulinum toxin. Dis Mon 2002; 48(5): 336-56.
13. Naumann M, Zellner M, Toyka KV, Reiners K. Treatment of gustatory sweating with botulinum toxin. Ann Neurol 1997; 42 (6): 973-5.